Table 1. Patient characteristics.

Characteristic	N=120 (%)
Median follow-up	49.9 months
(range)	(3.3–97.6)
Median age	57 years
(range)	(33–80)
Sex
Female	29 (24)
Male	91 (76)
Performance status
0	2 (2)
1	118 (98)
HPV status
Positive	74 (62)
Negative	26 (22)
Unknown	20 (16)
Tumour site
Oropharynx	110 (92)
Hypopharynx	10 (8)
T stage
T1	25
T2	51
T3	23
T4	21
N stage
N0	23
N1	17
N2a	10
N2b	46
N2c	22
N3	2
AJCC stage
I	1 (1)
II	10 (8)
III	19 (16)
IVa	88 (73)
IVb	2 (2)
Induction chemotherapy
Cisplatin+5-Flurouracil (PF)	69 (58)
Carboplatin+5-Flurouracil (Carbo-F)	7 (6)
1PF+1 Carbo-F	5 (4)
1PF or 1 Carbo-F	2 (2)
Docetaxel+Cisplatin+5-Flurouracil	3 (3)
Concomitant chemotherapy
Cisplatin (P)	65 (54)
Carboplatin (carbo)	20 (17)
1 P +1 Carbo	14 (12)
Cetuximab	2 (2)
Radiotherapy
Primary	103 (87)
Postoperative	17 (13)